Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
01/2003
01/02/2003EP1270577A1 Furoisoquinoline derivatives, process for producing the same and use thereof
01/02/2003EP1270567A1 Pyrazoline derivatives or tetrahydropyridazine derivatives and medicinal use thereof
01/02/2003EP1270549A1 Polymer-immobilized alpha-iminoester
01/02/2003EP1268498A1 Cardioprotective phosphonates and malonates
01/02/2003EP1268482A1 Pyranoindoles for treating glaucoma
01/02/2003EP1268444A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents
01/02/2003EP1268437A1 Inhibitors of protein kinases
01/02/2003EP1268412A1 Sulphonamido-substituted bridged bicycloalkyl derivatives
01/02/2003EP1268408A1 Arthropodicidal carboxanilides
01/02/2003EP1109785B1 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
01/02/2003EP1073654A4 2,3-olefinic epothilone derivatives
01/02/2003EP1073648A4 12,13-modified epothilone derivatives
01/02/2003EP1073647A4 12,13-cyclopropane epothilone derivatives
01/02/2003EP0804431B9 GLYCOPROTEIN IIb/IIIa ANTAGONISTS
01/02/2003EP0705245B1 Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
12/2002
12/31/2002US6500962 Production method of α-methylene-γ-butyrolactones
12/31/2002US6500953 Preparation of camptothecin and nothapodytine derivatives
12/31/2002US6500855 Nitrogen containing aromatic heterocycles with ortho-substituted p1 groups; anticoagulants
12/31/2002US6500843 Inhibitors of rotamase enzyme activity
12/31/2002US6500824 Psychosis, or paralysis due to ischemic spinal cord injury.
12/27/2002WO2002102978A2 Human growth hormone antagonists
12/27/2002WO2002102803A1 Total synthesis of galanthamine, analogues and derivatives thereof
12/27/2002WO2002102793A2 Quinazolinediones as antibacterial agents
12/27/2002WO2002102372A1 Gem-disubstituted cyclohexane derivatives and their use as therapeutic agents
12/27/2002WO2002102315A2 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
12/27/2002WO2002102314A2 Purine inhibitors of phosphodiesterase (pde) 7
12/27/2002WO2002102313A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002WO2002088127A3 Triazolopyrimidines
12/27/2002WO2002074776A3 Highly purified and crystalline form of harringtonine
12/27/2002CA2450936A1 Purine inhibitors of phosphodiesterase (pde) 7
12/27/2002CA2450934A1 Pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002CA2450724A1 Quinazoline and pyrido¬2,3-d|pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002CA2449977A1 Human growth hormone antagonists
12/27/2002CA2446963A1 Quinazolinediones as antibacterial agents
12/26/2002US20020198407 Antiallergy agents and bronchodilators
12/26/2002US20020198236 Small organic molecule regulators of cell proliferation
12/26/2002US20020198195 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa
12/26/2002US20020198194 Neuropeptide Y (NPY) antagonists for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders, or obesity
12/26/2002US20020198141 Molecular conjugates for use in treatment of cancer
12/26/2002US20020197561 Information layer comprises a light-absorbent compound that is a dye which cyclizes thermally
12/26/2002US20020197439 Optical data storage medium containing a triazacyanine dye as the light-absorbing compound in the information layer
12/25/2002CN1387532A Naphthopyrans with heterocyclic in 5,6-position, preparation, and compositions and matrices contg. them
12/25/2002CN1387528A Heterocyclic substd, pyrazolones
12/25/2002CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor
12/25/2002CN1097056C Counterpart of camptothecin, their application as medicine and pharmaceutical compositions contg. them
12/25/2002CN1097055C Taxena derivs., preparation thereof formulation contg. them
12/25/2002CN1097054C Tricyclic pyrazole derivs. and composition
12/25/2002CN1097053C 1,2,3,4-tetrahydro-benzofuro [3,2-c] pyridine derivs., preparing method and use thereof
12/24/2002US6498257 2,3-olefinic epothilone derivatives
12/24/2002US6498251 Tetrahydrobenzindole derivatives
12/24/2002US6498165 Pyrimidine compounds; prophylaxis and treatment of such as immune diseases, hyperproliferative disorders, cancer, angiogensis, atheroscelerosis, graft rejection, rheumatoid arthritis, psoriasis
12/24/2002US6498161 Treating infection by hiv; delaying of the onset of aids; asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis or rheumatoid arthritis
12/24/2002US6498159 Such as 4-((3-chloro-4-methoxybenzyl)amino)-1-((4-hydroxy-4 -hydroxymethyl)piperidino)-6-phthalazine carbonitrile
12/19/2002WO2002100886A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa
12/19/2002WO2002100860A2 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
12/19/2002WO2002100857A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
12/19/2002WO2002100832A1 Isoquinoline compounds having antiinfective activity
12/19/2002WO2002100319A2 Method for cleaning hard gelatine capsules
12/19/2002WO2002088144A3 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO[2,3-f]QUINOXALINE
12/19/2002WO2002083651A3 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
12/19/2002WO2002080161A3 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
12/19/2002WO2002070541A3 Peptide deformylase inhibitors
12/19/2002WO2002060894A3 Sulfonamide lactam inhibitors of factor xa
12/19/2002WO2002050082A3 Inhibitors of papilloma virus
12/19/2002US20020193598 7-(trialkylsilylalkyl)-camptothecin of given formula by cyclizing a 4-hydroxy-6-halo,7-(trialkylsilylalkyl)-3,4,7,8-tetrahydro-1h-pyrano(3,4 -c)pyridin-3,8-dione with an aryl isonitrile
12/19/2002US20020193405 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases
12/19/2002US20020193387 As antimalarial agent
12/19/2002US20020193366 Azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]-quinoline as 5-HT1A antagonists
12/19/2002US20020193361 For therapy of cancer and other conditions characterized by abnormal cellular proliferation
12/19/2002DE10115227A1 Optischer Datenträger enthaltend in der Informationsschicht eine lichtabsorbierende Verbindung mit mehreren chromophoren Zentren Optical data storage medium in the information layer containing a light absorbing compound having a plurality of chromophoric centers
12/19/2002CA2450625A1 Isoquinoline compounds having antiinfective activity
12/19/2002CA2445467A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
12/18/2002EP1266896A1 Linear ou cyclic ureas, process for their preparation and pharmaceutical compositions containing them
12/18/2002EP1266887A2 Indenoindoline derivatives, their process of preparation and pharmaceutical compositions containing them
12/18/2002EP1265902A1 Method for producing sulfonyl imidazole derivatives by phase transfer catalysis
12/18/2002EP1265878A1 A process for the preparation of epothiline analogs and intermediates
12/18/2002EP0880526B1 Heterocycle-condensed morphinoid derivatives (ii)
12/18/2002CN1385432A Method for purifying tetrodotoxin
12/18/2002CN1385431A Process for large-scale preparing tetrodotoxin high-purity monomer
12/18/2002CN1385422A Process for preparing 2-azadihydroxy bicycle heptane compound
12/18/2002CN1096464C 2,3-benzodiazepine derivatives, its preparation and intermediate and use as medicine
12/18/2002CN1096463C Procss for producing ecteinascidin and intermediate of said process
12/18/2002CN1096462C 7,12-dioxabenz [a] anthracene compounds, process for preparing them and pharmaceutical compositions containing them
12/17/2002US6495555 Tricyclic Δ-3-piperidines as α2-antagonists
12/16/2002WO2004055020A1 Process for the direct preparation of 5-alkoxy and 5-acyloxy analogues of campthothecins or mappicene ketones
12/12/2002WO2002099077A2 Methods and compositions related to tagging of membrane surface proteins
12/12/2002WO2002098868A1 Epothilone derivatives
12/12/2002WO2002098865A2 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
12/12/2002WO2002098863A1 Fused imidazole derivative
12/12/2002WO2002098860A1 Novel fused indazoles and indoles and their use for the treatment of glaucoma
12/12/2002WO2002098854A2 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
12/12/2002WO2002098424A1 Novel anti-infectives
12/12/2002WO2002098350A2 Pyranoindazoles and their use for the treatment of glaucoma
12/12/2002US20020188136 Pesticides and herbicides
12/12/2002US20020188124 Novel spiro compounds
12/12/2002US20020188014 Polymorphs of an epothilone analog
12/12/2002US20020187994 New compounds
12/12/2002US20020187992 Prodrugs via acylation with cinnamate
12/12/2002US20020187983 Process for the synthesis of derivatives of 2, 3-dihydro-1, 4-dioxino- [2, 3-f] quinoline
12/12/2002US20020187978 4-Heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors